236
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Development, characterisation and pharmacoscintigraphic evaluation of nano-fluticasone propionate dry powder inhalation as potential antidote against inhaled toxic gases

, , , , , & show all
Pages 546-558 | Received 06 Jun 2012, Accepted 24 Dec 2012, Published online: 04 Feb 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (3)

Shaimaa Ahmed, Thirumala Govender, Inamullah Khan, Nisar ur Rehman, Waqar Ali, Syed Muhammad Hassan Shah, Shahzeb Khan, Zahid Hussain, Riaz Ullah & Mansour S Alsaid. (2018) Experimental and molecular modeling approach to optimize suitable polymers for fabrication of stable fluticasone nanoparticles with enhanced dissolution and antimicrobial activity. Drug Design, Development and Therapy 12, pages 255-269.
Read now
Gaurav Mittal, Neeraj Kumar, Harish Rawat, Abhinav Jaimini, Mitrabasu Chhillar & Aseem Bhatnagar. (2016) Development and clinical study of submicronic-atropine sulphate respiratory fluid as a novel organophosphorous poisoning antidote. Drug Delivery 23:7, pages 2255-2261.
Read now
Mohamed Ehab Ali, Jason T McConville & Alf Lamprecht. (2015) Pulmonary delivery of anti-inflammatory agents. Expert Opinion on Drug Delivery 12:6, pages 929-945.
Read now

Articles from other publishers (11)

Priti Y. Rai, Vipul A. Sansare, Deepa U. Warrier & Ujwala A. Shinde. (2023) Formulation, characterization and evaluation of inhalable effervescent dry powder of Rifampicin nanoparticles. Indian Journal of Tuberculosis 70:1, pages 49-58.
Crossref
Georgia Michailidou & Dimitrios N. Bikiaris. (2022) Novel 3D-Printed Dressings of Chitosan–Vanillin-Modified Chitosan Blends Loaded with Fluticasone Propionate for Treatment of Atopic Dermatitis. Pharmaceutics 14:9, pages 1966.
Crossref
Valérie Forest & Jérémie Pourchez. (2022) Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?. Advanced Drug Delivery Reviews 183, pages 114173.
Crossref
Tuangrat Praphawatvet, Jay I. Peters & Robert O. WilliamsIIIIII. (2020) Inhaled nanoparticles–An updated review. International Journal of Pharmaceutics 587, pages 119671.
Crossref
Vijaykumar SutariyaShannon J. KellyRobert G. WeigelJared TurKathleen HalaszNirmal S. SharmaSrinivas M. Tipparaju. (2019) Nanoparticle drug delivery characterization for fluticasone propionate and in vitro testing. Canadian Journal of Physiology and Pharmacology 97:7, pages 675-684.
Crossref
Manisha Lalan, Hemal Tandel, Rohan Lalani, Vivek Patel & Ambikanandan Misra. 2019. Novel Drug Delivery Technologies. Novel Drug Delivery Technologies 291 333 .
Kamarza Mulia, Nur Halimah & Elsa Krisanti. Effect of alginate composition on profile release and characteristics of chitosan-alginate microparticles loaded with mangosteen extract. Effect of alginate composition on profile release and characteristics of chitosan-alginate microparticles loaded with mangosteen extract.
Virendra Pratap Singh Rathor, Pradeep Chugh, Rashid Ali, Anuj Bhatnagar, Syed Ehtaishamul Haque, Aseem Bhatnagar & Gaurav Mittal. (2016) Formulation, preclinical and clinical evaluation of a new submicronic arginine respiratory fluid for treatment of chronic obstructive pulmonary disorder. Saudi Pharmaceutical Journal 24:1, pages 49-56.
Crossref
M. López-Heras, I. G. Theodorou, B. F. Leo, M. P. Ryan & A. E. Porter. (2015) Towards understanding the antibacterial activity of Ag nanoparticles: electron microscopy in the analysis of the materials-biology interface in the lung. Environmental Science: Nano 2:4, pages 312-326.
Crossref
Sudha Rana, Amit Tyagi, Nabo Kumar Chaudhury & Rakesh Kumar Sharma. 2015. Targeted Drug Delivery : Concepts and Design. Targeted Drug Delivery : Concepts and Design 667 686 .
Mukta Paranjpe & Christel Müller-Goymann. (2014) Nanoparticle-Mediated Pulmonary Drug Delivery: A Review. International Journal of Molecular Sciences 15:4, pages 5852-5873.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.